Deborah Zanforlin

  • Grey LinkedIn Icon

CEO & Co-founder

Deborah has extensive knowledge in biosensing gained through 9 years of research in the field of clinically relevant biosensors at Univ. Federal de Pernambuco with 4 granted patents, and through being a former biochemistry professor at DeVry Brazil. 

Jakub Chudik

  • Grey LinkedIn Icon


Jakub has expertise in Machine Learning, software development, and hardware prototyping gained at MIT (MIT Computational Biology Group), National University of Singapore, and Expedia. 

The growing power from around the globe meeting at MIT


Jeff Grossman

  • Grey LinkedIn Icon

MIT Professor of Materials Science & Engineering

Materials Chemistry; Nanotechnology

Gerrit Kuijt

  • Grey LinkedIn Icon

Former Medical Director of Surgery at Maxima Medical Center, Founded Specialty Physician Group

Brian Healey

  • Grey LinkedIn Icon

20+ years in oncology, assay development and biomarkers; former director EMD Serono.

John Hamilton

  • Grey LinkedIn Icon

25+ years in startups;

experienced with fundraising, IPO and acquisitions

Jorge Sanchez

  • Grey LinkedIn Icon

Serial Entrepreneur;

B2B & Sales Expertise;

Seth Godin’s altMBA




ConquerX aims to revolutionize early-stage cancer detection, making it affordable and available to all. The technology was ideated by Deborah Zanforlin after she made a key discovery that would enable the development of a new type of blood test able to detect cancers in early stages. Born and raised in Recife, Brazil, Deborah had experienced first-hand the basic healthcare needs in a developing country.  At the MIT Entrepreneurship Bootcamp, together with Jakub Chudik,  Jorge Sanchez and To-Nhu Huynh, the company was founded (2015).

  • Facebook Social Icon
  • https://www.linkedin.com/in/conquerx
Boston, USA
UMass-Boston, Wheatley Hall, 3rd Floor
100 Morrissey Boulevard, Boston MA 02125 USA
Cambridge, UK
Unit 6 Queens Yard, London, E9 5EN, United Kingdom.

This project has received funding from the European Union's Horizon 2020 SME Instrument program under grant agreement nr 854871

©2018 ConquerX. All rights reserved